Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2017

Open Access 01-12-2017 | Research article

Potential effectiveness of Chinese herbal medicine Yu ping feng san for adult allergic rhinitis: a systematic review and meta-analysis of randomized controlled trials

Authors: Qiulan Luo, Claire Shuiqing Zhang, Lihong Yang, Anthony Lin Zhang, Xinfeng Guo, Charlie Changli Xue, Chuanjian Lu

Published in: BMC Complementary Medicine and Therapies | Issue 1/2017

Login to get access

Abstract

Background

Chinese herbal medicine formula Yu ping feng san (YPFS) is commonly used for allergic rhinitis (AR). Previous review had summarized the effectiveness and safety of YPFS, however without any subgroup analysis performed to provide detailed evidence for guiding clinical practice. YPFS was recommended for the management of AR by Chinese medicine clinical practice guideline, but the treatment duration of YPFS was also not specified. The aim of this study is to evaluate the effectiveness and safety of YPFS in treating adult AR with the most recent evidence, and attempt to specify the duration of utilisation through subgroup meta-analyses.

Methods

Seven databases were searched from their inceptions to September 2017. Randomized controlled trials (RCTs) evaluating YPFS for adult AR were included. Methodological quality of studies was assessed using the Cochrane risk of bias tool. Meta-analysis and subgroup meta-analyses were conducted for evaluating the effectiveness of YPFS. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used for rating the quality of evidence.

Results

Twenty-two RCTs involving 23 comparisons were included in this review. YPFS was compared to placebo, pharmacotherapy, and used as an add-on treatment compared to pharmacotherapy. Meta-analyses were feasible for the outcomes of four individual nasal symptom scores and “effective rate”. Four individual nasal symptom scores decreased after YPFS’ combination treatment: itchy nose (MD-0.46, 95% CI[−0.50, −0.42]), sneezing (MD-0.41, 95% CI[−0.47, −0.35]), blocked nose (MD-0.46, 95% CI[−0.54, −0.39]) and runny nose (MD-0.42, 95% CI[−0.58, −0.26]). Based on “effective rate”, meta-analysis showed that YPFS did not achieve better effect than pharmacotherapy (RR1.07, 95%CI [0.94, 1.22), but its combination with pharmacotherapy seemed more effective than pharmacotherapy alone (RR1.27, 95%CI [1.19, 1.34]) (low quality). Subgroup analysis suggested that YPFS was not superior to the second-generation antihistamine (RR1.04, 95%CI [0.90, 1.19]) (low quality). Further, YPFS’ combination treatment seemed more beneficial when it was used for more than three weeks (RR1.15, 95%CI [1.01, 1.32]). In addition, YPFS was well-tolerated for treating adult AR.

Conclusion

Chinese herbal medicine formula YPFS seems beneficial for adult AR. This potential benefit need to be further evaluated by more rigorous RCTs.
Appendix
Available only for authorised users
Literature
1.
Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA (2)LEN and AllerGen). Allergy. 2008;63:8–160.CrossRefPubMed
2.
Dykewicz MS, Fineman S, Skoner DP, Nicklas R, Lee R, Blessing-Moore J, Li JT, Bernstein IL, Berger W, Spector S, Schuller D. Diagnosis and management of rhinitis: complete guidelines of the joint task force on practice parameters in allergy, asthma and immunology. American Academy of allergy, asthma, and immunology. Ann Allergy Asthma Immunol. 1998;81:478–518.CrossRefPubMed
3.
Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol. 2001;108(Suppl 1):2–8.CrossRef
4.
Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, van Wijk RG, Ohta K, Zuberbier T, Schünemann HJ. Global allergy and asthma European network and grading of recommendations assessment. Development and evaluation working group. Allergic rhinitis and its impact on asthma (ARlA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126:466–76.CrossRefPubMed
5.
Seidman MD, Gurgel RK, Lin SY, Schwartz SR, Baroody FM, Bonner JR, et al. Clinical practice guideline: Allergic rhinitis. Otolaryngol Head Neck Surg. 2015;152(Suppl 1):1–43.CrossRef
6.
Scadding GK, Durham SR, Mirakian R, Jones NS, Leech SC, Farooque S, et al. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy. 2008;38:19–42.CrossRefPubMed
7.
Bousquet J, van Cauwenberge P, Khaltaev N, Canonica GW, Khaltaev N, Carlsen KH, et al. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108:147–334.CrossRef
8.
Wang SJ, Tang QF, Qian W, Fan Y. Meta-analysis of clinical trials on traditional Chinese herbal medicine for treatment of persistent allergic rhinitis. Allergy. 2012;67:583–92.CrossRefPubMed
9.
.Bi Qiu (allergic rhinitis). In: China Association of Chinese Medicine. Diagnosis and Treatment Guidelines in Traditional Chinese Medicine for Common Otolaryngology Disease. Beijing, China: Chinese Traditional Chinese Medicine Publishing House, 2012.p. 17–8. [Article in Chinese].
10.
Yu ping feng san. In: Li F. Prescriptions of Traditional Chinese Medicine. Beijing, China: People’s Medical Publishing House; 2002. p. 817–26. [Article in Chinese].
11.
Zhang JQ. Systematic Review of Jiawei Yupingfeng Powder on Intervention of Allergic Rhinitis Effects and Safety. J Basic Chin Med. 2016;22: 99–101. [Article in Chinese].
12.
13.
14.
15.
Feng WY, Wang XP, Zhang M, Wei ZZ, Fang YF. Clinical effect observation of Allergic Rhinitis Oral Liquid in treating perennial allergic rhinitis. J Guangzhou Univ Tradit Chin Med. 2004;21:101–4. [Article in Chinese].
16.
Fang XY, Feng SS, Li Y, Zhang XT, Zhu Y, Zhan G. Clinical efficacy of Yupingfeng capsule in treating allergic rhinitis and its safety evaluation. Chin Arch Tradit Chin Med. 2014;32: 2556–8. [Article in Chinese].
17.
Wang XD. Clinical effect observation of modified Yu ping feng san in treating allergic rhinitis with Lung and Spleen qi deficiency. Med Aesthet Beauty (midmonth). 2014;23:258. [Article in Chinese].
18.
Luo HW. Modified Yu ping feng san treat allergic rhinitis with Lung and Spleen deficiency-cold (60 cases). Tradit Chin Med Res. 2012;25:35–6. [Article in Chinese].
19.
Wu GH, Li L, Cao CM, Nan NY. Clinical effect observation of Yu ping zhi ti granule in treating allergic rhinitis. Chin J Otorhinolaryngol Integr Med. 2013;21:51–2. [Article in Chinese].
20.
Wang XH. Clinical effect observation of modified Yu ping feng san in treating perennial allergic rhinitis. Master dissertation: Beijing University of Chinese Medicine; 2009. [Article in Chinese]
21.
Guo HL, Liu JJ, Zhao YL. An effective analysis of treating allergic rhinitis with the Yu ping feng granules (35Cases). Clin J Chin Med. 2015;7(35):82–3. [Article in Chinese].
22.
Yao SG. Curative effect observation of modified Cang er yu ping decoction for allergic rhinitis. Chin J of Tradit Med Sci Techno. 2015;22(3):309–10. [Article in Chinese].
23.
Yu WX, Jiang YL. Clinical effect observation of Chinese and western medicine combined treatment for the treatment of allergic rhinitis. J Sichuan Tradit Chin Med. 2012;30:88–9. [Article in Chinese].
24.
Shi HY, Zhuang Y, Wang XY. Clinical effect observation of Yu ping feng droppill in treatment of allergic rhinitis. Chin J Chin Mater Med. 2014;39:2364–6. [Article in Chinese].
25.
Lu YQ. Clinical effect observation of Yu ping feng granule in the adjuvant treatment for persistent allergic rhinitis. J Clin Exp Med. 2014;13:550–2. [Article in Chinese].
26.
Zhou WR, Zhang JX. Clinical effect observation of Chinese and western medicine integrative treatment for allergic rhinitis (36 cases). Jiangsu J Tradit Chin Med. 2010;42:42. [Article in Chinese].
27.
Huang J. Clinical analysis of Chinese and western medicine integrative treatment for allergic rhinitis. For all Health. 2014;8:17–8. [Article in Chinese].
28.
Liu GR. Clinical effect observation of modified Yu ping feng san in treating perennial allergic rhinitis with deficiency of the lung-qi. Master dissertation: Fujian University of Chinese Medicine; 2012. [Article in Chinese]
29.
Chen L, Chen XW. Clinical effect observation of Cetirizine combined with Yupingfeng san in treating allergic rhinitis. World Chin Med. 2014;9:880–2. [Article in Chinese].
30.
Lin YG. Clinical effect observation of modified Yu ping feng san in the treatment for perennial allergic rhinitis with the lung-qi deficiency cold, and the changes of interleukin-2 (IL-2) and interleukin-4(IL-4). Master dissertation: Fujian University of Chinese Medicine; 2014. [Article in Chinese]
31.
Guan CL. Clinical effect observation of jade screen powder combined with budesonide nasal spray in the treatment for allergic rhinitis. Chin Med Pharm. 2013;3:71–2. [Article in Chinese].
32.
Chen ZJ, Wang WH, liu B, Zhao XY. Effects of Azelastine nasal spray plus Yu ping feng decoction on serum levels of IgE and peripheral eosinophils of allergic rhinitis patients. Mod J Integr Tradit Chin West Med. 2015;24(36):4040–2. [Article in Chinese].
33.
Ma JJ. Effects of Yu ping feng granule combined with mizolastine on inflammatory factors and immune function in patients with allergic rhinitis. J North Pharm. 2017;14(7):105–6. [Article in Chinese].
34.
Qiu HJ. Clinical effect of Yu ping feng granule combined with Ebastine in the treatment of allergic rhinitis. Inter Med Heal Gui News. 2017;23(4):533–5. [Article in Chinese].
35.
Zheng WW, Chen XH, Li HT, Luo YZ, Han JQ. Curative effect observation of Yu ping feng granule combined with cetirizine in the treatment of allergic rhinitis. Chin Mod Doc. 2017;55(10):73–9. [Article in Chinese].
36.
Society of Otorhinolaryngology, Chinese Medical Association; Editorial Board of Chinese Journal of Otorhinolaryngology. Criteria for diagnosis and therapeutic evaluation of allergic rhinitis (Revised in 1997, Haikou). Zhonghua Er Bi Yan Hou Za Zhi. 1998;33:134-5. [Article in Chinese].
37.
Editorial Board of Chinese Journal of Otorhinolaryngology Head and Neck Surgery, Chinese Otorhinolaryngology Society of Chinese Medical Association. Diagnostic and treatment principle for allergic rhinitis and a recommended scheme (2004, Lanzhou). Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2005;40:166-7. [Article in Chinese].
38.
Bi Qiu (allergic rhinitis). In: State Administration of Traditional Chinese Medicine of the People’s Republic of China. Standard of Diagnosis and Assessment of Treatment Effects of otolaryngological Conditions in Chinese Medicine. Nanjing; 1994. p. 24. [Article in Chinese].
39.
Chinese medicine clinical research guiding principles of new drugs for Bi Qiu (allergic rhinitis).In: Ministry of Health of the People’s Republic of China. Chinese medicine clinical research guiding principles of new drugs (the third version). Beijing, China; 1997. p. 170–2. [Article in Chinese].
40.
Kong CM, Zhao ZJ, Zhong XH. Effects of Gan lian Yu ping feng powder on the antibody titers to infectious laryngotracheitis vaccine and some nonspecific immune indexes in chickens. Afr J Tradit Complement Altern Med. 2013;10(4):70–7.
41.
Makino T, Sasaki SY, Ito Y, Kano Y. Pharmacological properties of traditional medicine (XXX): effects of Gyokuheifusan ([玉屏風散]) on murine antigen-specific antibody production. Biol Pharm Bull. 2005;28(1):110–3.CrossRefPubMed
42.
Gao J, Li J, Shao X, Jin Y, Lü XW, Ge JF, Huang Y, Zhang L, Chen L. Antiinflammatory and immunoregulatory effects of total glucosides of Yupingfeng powder. Chin Med J. 2009;122(14):1636–41.PubMed
43.
Bousquet J, Bachert C, Canonica GW, Casale TB, Cruz AA, Lockey RJ, Zuberbier T. Extended global allergy and asthma European network and world allergy organization and allergic rhinitis and its impact on asthma study group. Unmet needs in severe chronic upper airway disease (SCUAD). J Allergy ClinImmunol. 2009;124:428–33.CrossRef
44.
Hellings PW, Fokkens WJ, Akdis C, Bachert C, Cingi C, Dietz de Loos D, et al. Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today. Allergy. 2013;68:1–7.CrossRefPubMed
45.
Dong H. Modified Yu ping feng san combined with Cetirizine treated allergic rhinitis (32 cases). Mod J Integr Tradit Chin West Med. 2012;21:984–985. [Article in Chinese].
46.
Li XY. Clinical effect observation of modified Yu ping feng san combined with Cetirizine treated allergic rhinitis (50 cases). Jilin Med J. 2013;34:460. [Article in Chinese].
47.
Zou LL, Zou SS, Xiong SW, Wu XZ. Yu ping feng oral liquid on the inhibition of influenza virus and its influence on the body’s immune function. J Chin Med Materials.1990;13:37–40. [Article in Chinese].
48.
Yu ping feng san. In: Ji YB. Compound Chinese Medicine Pharmacology and Application. Beijing, China: China Medical Science and Technology Press; 2005. p. 672–80. [Monograph in Chinese].
49.
Wen J, Zhu JM, Li J, Yuan GM, Xiang FJ. Experimental study of Yu ping feng san on allergic rhinitis in rat and guinea pig. Chin Tradit Patent Med. 2011;33:934–7. [Article in Chinese].
50.
Tong L, Liu JL, Wang JX, Sun LL, Song YL, Tian GY, He S, Gao YJ. Effect of Yupingfeng granule on cytokines of allergic rhinitis induced by OVA in rats. Chin J Chin Mater Med. 2016;41:728–30. [Article in Chinese].
51.
Zhang ZL, Zhong L, Ling BD, Yuan MY. Effect of Yu ping feng san on activity of IL-6 and TNF-α in rats with allergic rhinitis. Chin Tradit Patent Med. 2014;36:1804–9. [Article in Chinese].
52.
Zhang ZL, Zhong L, Ling BD, Yuan MY. Experimental research of Yu ping feng san in regulating the activity of mast cells in the allergic rhinitis based on interleukin-3 and GM-CSF. J Chengdu Med College. 2014;9:392–6. [Article in Chinese].
53.
Xin HT, Hou LJ, Xu SH, Zhou XH. Immune pharmacological research progress of Yu ping feng san, Chin J Chin Mater Med. 1998;23:505–7. [Article in Chinese].
54.
55.
Shen HH, Wang K, Li W, Ying YH, Gao GX, Li XB, Huang HQ. AstragalusMembranaceus prevents airway hyperreactivity in mice related to Th2 response inhibition. J Ethnopharmacol. 2008;116:363–9.CrossRefPubMed
56.
Lee YS, Han OK, Park CW, Yang CH, Jeon TW, Yoo WK, Kim SH, Kim HJ. Pro-inflammatory cytokine gene expression and nitric oxide regulation of aqueous extracted Astragali radix in RAW 264.7 macrophage cells. J Ethnopharmacol. 2005;100:289–94.CrossRefPubMed
57.
Khan S, Shin EM, Choi RJ, Jung YH, Kim J, Tosun A, Kim YS. Suppression of LPS-induced inflammatory and NF-kappaB responses by anomalin in RAW 264.7 macrophages. J Cell Biochem. 2011;112:2179–88.CrossRefPubMed
58.
Dong HY, He LC, Huang M, Dong Y. Anti-inflammatory components isolated from AtractylodesmacrocephalaKoidz. Nat Prod Res. 2008;22:1418–27.CrossRefPubMed
59.
Editorial Board of Chinese Journal of Otorhinolaryngology (Data sorting by Gu ZY). Criteria for diagnosis and therapeutic evaluation of allergic rhinitis. Zhonghua Er Bi Yan Hou Za Zhi. 1991;26:134. [Article in Chinese].
60.
Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (Clinical research ed). 2010;c332:340.
61.
Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med. 2006;144(5):364–7.CrossRefPubMed
Metadata
Title
Potential effectiveness of Chinese herbal medicine Yu ping feng san for adult allergic rhinitis: a systematic review and meta-analysis of randomized controlled trials
Authors
Qiulan Luo
Claire Shuiqing Zhang
Lihong Yang
Anthony Lin Zhang
Xinfeng Guo
Charlie Changli Xue
Chuanjian Lu
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2017
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-017-1988-5

Other articles of this Issue 1/2017

BMC Complementary Medicine and Therapies 1/2017 Go to the issue

Research article

Association of lumbar spine stiffness and flexion-relaxation phenomenon with patient-reported outcomes in adults with chronic low back pain – a single-arm clinical trial investigating the effects of thrust spinal manipulation

Research article

Prevalence and associations for use of a traditional medicine provider in the SAMINOR 1 Survey: a population-based study on Health and Living Conditions in Regions with Sami and Norwegian Populations

Research article

Neuroprotective effect of Demethoxycurcumin, a natural derivative of Curcumin on rotenone induced neurotoxicity in SH-SY 5Y Neuroblastoma cells

Research article

Anti-allodynic effect of Buja in a rat model of oxaliplatin-induced peripheral neuropathy via spinal astrocytes and pro-inflammatory cytokines suppression

Research article

Pregnancy, prescription medicines and the potential risk of herb-drug interactions: a cross-sectional survey

Research article

Antioxidant activity, acetylcholinesterase inhibitory potential and phytochemical analysis of Sarcocephalus latifolius Sm. bark used in traditional medicine in Sudan